Loading clinical trials...
Loading clinical trials...
A Randomized Controlled, Single-blind, Proof-of-concept-study to Investigate the Protective Effects of Early Treatment With C.E.R.A. in Patients With Chronic Kidney Disease on Renal Disease Progression (PRIMAVERA-Study)
Conditions
Interventions
Methoxy polyethylene glycol-epoetin beta
Placebo
Locations
33
Germany
Uniklinik RWTH Aachen; Med. Klinik II; Klinik für Nephrologie und klinische Immunologie
Aachen, Germany
Dialysepraxis Dr. Stallforth, Dr. Kirschner, Dr. Al-Sarraf und Dr. Pawlik
Augsburg, Germany
KfH Kuratorium für Dialyse und Nierentransplantation e.V. im Kurhaus
Bad König, Germany
Charité - Klinikum Mitte; Medizinische Klinik Für Nephrologie
Berlin, Germany
Charité - Campus Benjamin Franklin; Zentrum fuer Innere Medizin, Med. Klinik I
Berlin, Germany
Gemeinschaftspraxis Dres. Erika Eger, Frank Seibt, Oliver Eike u.w. - Dialysezentrum Treptower Park
Berlin, Germany
Start Date
September 30, 2010
Primary Completion Date
March 31, 2015
Completion Date
March 31, 2015
Last Updated
May 10, 2017
NCT07374042
NCT06343727
NCT07217535
NCT06841692
NCT06863194
NCT07471802
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions